
    
      In a randomized double-blind placebo-controlled clinical trial Shirazi's Thyme is compared
      with placebo. Investigators select randomly 90 patients with NAFLD by inclusion criteria.
      Investigators measure anthropometric and laboratory parameters including fasting blood sugar,
      insulin, liver enzymes, lipid profile, and grade in sonography before intervention and 90
      days later. Patients are divided into two equal groups. Intervention group in addition to
      diet and exercise recommendations receive capsules containing 700 mg of Shirazi thyme powder
      daily for 90 days. Placebo group in addition to the same recommendations for diet and
      exercise, receives placebo capsules twice daily.
    
  